Accessibility Menu
Simulations Plus Stock Quote

Simulations Plus (NASDAQ: SLP)

$17.52
(-0.6%)
-0.10
Price as of October 23, 2025, 3:12 p.m. ET

KEY DATA POINTS

Current Price
$17.52
Daily Change
(-0.6%) $0.10
Day's Range
$17.34 - $18.43
Previous Close
$17.62
Open
$17.62
Beta
1.04
Volume
344,862
Average Volume
525,569
Market Cap
354.6M
Market Cap / Employee
$17.62M
52wk Range
$12.39 - $37.67
Revenue
-
Gross Margin
0.54%
Dividend Yield
N/A
EPS
-$3.14
CAPs Rating
-
Industry
Health Care Technology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Simulations Plus Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
SLP-48.55%-74.34%-23.82%+1,543%
S&P+14.5%+93.32%+14.09%+654%

Simulations Plus Company Info

Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. The firm operates through the Software and Services segment. It designs and develops pharmaceutical simulation software to promote cost-effective solutions to a number of problems in pharmaceutical research and in the education of pharmacy and medical students. The company was founded by Walter S. Woltosz and Virginia E. Woltosz on July 17, 1996 and is headquartered in Lancaster, CA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$20.36M9.8%
Gross Profit$13.03M-1.7%
Gross Margin64.00%-7.5%
Market Cap$640.43M-33.6%
Market Cap / Employee$2.59M0.0%
Employees2470.0%
Net Income-$67.32M-2245.9%
EBITDA$5.30M68.5%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$26.95M-75.3%
Accounts Receivable$18.98M37.1%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$0.45M-12.1%
Short Term Debt$0.27M-34.4%

Ratios

Q2 2025YOY Change
Return On Assets-38.64%-43.8%
Return On Invested Capital6.01%-3.5%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$7.85M41.0%
Operating Free Cash Flow$8.14M43.3%

Valuation

MetricQ2 2024Q3 2024Q4 2024Q1 2025YoY Change
Price to Earnings101.6474.0178.6281.111.22%
Price to Book4.013.493.153.38-36.69%
Price to Sales10.388.657.487.97-45.86%
Price to Tangible Book Value5.6223.1518.8817.35131.75%
Price to Free Cash Flow TTM91.3484.3664.8951.09-52.42%
Enterprise Value to EBITDA670.72233.00111.49115.73-58.08%
Free Cash Flow Yield1.1%1.2%1.5%2.0%110.15%
Return on Equity5.6%4.6%4.0%-41.5%-853.30%
Total Debt$1.01M$1.32M$0.80M$0.72M-22.02%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.